SEARCH

SEARCH BY CITATION

References

  • Althof SE, Corty EW, Levine SB, Levine F, Burnett AL, McVary K et al. (1999) EDITS: development of questionnaires for evaluating satisfaction with treatments for erectile dysfunction. Urology 53, 793799.
  • Barbul A. (1986) Arginine: biochemistry, physiology, and therapeutic implications. JPEN J Parenter Enteral Nutr 10, 227238.
  • Bode-Böger SM, Böger RH, Galland A, Tsikas D & Frölich JC. (1998) L-arginine induced vasodilation in healthy humans: pharmacokinetic-pharmacodynamic relationship. Br J Clin Pharmacol 46, 489497.
  • Böger RH & Ron ES. (2005) L-Arginine improves vascular function by overcoming the deleterious effects of ADMA, a novel cardiovascular risk factor. Altern Med Rev 10, 1423.
  • Boucharlat J, Salomon C, Maitre A, Pelat J & Wolf R. (1972) Etude clinique de l'Aspartate d'Arginine dans les impuissances sexuelles secondaires. Ann Med Psychol (Paris) 1, 394400.
  • Burnett AL, Lowenstein CJ, Bredt DS, Chang TS & Snyder SH. (1992) Nitric oxide: a physiologic mediator of penile erection. Science 257, 401403.
  • Chen J, Wollman Y, Chernichovsky T, Iaina A, Sofer M & Matzkin H. (1999) Effect of oral administration of high-dose nitric oxide donor L-arginine in men with organic erectile dysfunction: results of a double-blind, randomized, placebo-controlled study. BJU Int 83, 269273.
  • Chiang PH, Wu SN, Tsai EM, Wu CC, Shen MR, Huang CH et al. (1994) Adenosine modulation of neurotransmission in penile erection. Br J Clin Pharmacol 38, 357362.
  • Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ & McKinlay JB. (1994) Impotence and its medical and psychological correlates: results of the Massachusetts Male Aging Study. J Urol 151, 5461.
  • Filippi S, Mancini M, Amerini S, Bartolini M, Natali A, Mancina R et al. (2000) Functional adenosine receptors in human corpora cavernosa. Int J Androl 23, 210217.
  • Furchgott RF. (1988) Studies on relaxation of rabbit aorta by sodium nitrite : the basis for the proposal that the acid-activatable inhibitory factor from retractor penis is inorganic nitrite and the endothelium-derived relaxing factor is nitric oxide. In: Vasodilatation: Vascular Smooth Muscle, Peptides, Autonomic Nerves and Endothelium (ed. PM Vanhoutte), pp. 401404. Raven Press, New York.
  • Furchgott RF & Zawadzki JV. (1980) The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature (Lond) 288, 373376.
  • Gajdos A. (1974) AMP in porphyria cutanea tarda. Lancet 1, 163.
  • Gür S & Öztürk B. (2000) Altered relaxant responses to adenosine and adenosine 5'triphosphate in the corpus cavernosum from men and rats with diabetes. Pharmacology 60, 105112.
  • Hupertan V, Neuzillet Y, Stücker O, Pons C, Leammel E & Lebret T. (2012) Effects of nucleotides adenosine monophosphate and adenosine triphosphate in combination with l-arginine on male rabbit corpus cavernosum tissue. Int J Androl 106, 860866.
  • Ignarro LJ, Buga GM, Wood KS, Byrns RE & Chaudhuri G. (1987) Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 84, 925926.
  • Kataoka K, Furukawa K, Nagao K, Ishii N & Tsuru H. (2007) The participation of adenosine receptors in the adenosine 5'-triphosphate-induced relaxation in the isolated rabbit corpus cavernosum penis. Int J Urol 14, 764768.
  • Kim N, Azadzoi KM, Goldstein I & Saenz de Tejada I. (1991) A nitric oxide like factor mediates nonadrenergic-noncholinergic neurogenic relaxation of penile corpus cavernosum smooth muscle. J Clin Invest 88, 112118.
  • Klotz T, Mathers MJ, Braun M, Rajfer J & Gonzalez-Cadavid NF. (1999) Effectiveness of oral L-arginine in first-line treatment of erectile dysfunction in a controlled crossover study. Urol Int 63, 220223.
  • Lebret T, Herve JM, Gorny P, Worcel M & Botto H. (2002) Efficacy and safety of a novel combination of L-arginine glutamate and yohimbine hydrochloride: a new oral therapy for erectile dysfunction. Eur Urol 41, 608613.
  • Lerman A, Burnett JC Jr, Higano ST, Mckinley LJ & Holmes DR Jr. (1998) Long-term L arginine supplementation improves small-vessel coronary endothelial function in humans. Circulation 97, 21232128.
  • Malmary-Nebot MF, Oustrin J & Gauci M. (1979) The fate of adenosine monophosphate in the rat after a single oral administration. Influence of a simultaneous treatment by papaverine. Eur J Drug Metab Pharmacokinet 4, 97101.
  • Moody JA, Vernet D, Laidlaw S et al. (1997) Effects of long term oral administration of L Arginine on the rat erectile response. J Urol 158(3 pt 1), 942947.
  • Mulhall JP, Goldstein I, Bushmakin AG, Cappelleri JC & Hvidsten K. (2007) Validation of the erection hardness score. J Sex Med 4, 16261634.
  • O'Donnell AB, Araujo AB, Goldstein I & McKinlay JB. (2005) The validity of a single-question self-report of erectile dysfunction. Results from the Massachusetts Male Aging Study. J Gen Intern Med 20, 515519.
  • Palmer RM, Rees DD, Ashton DS & Moncada S. (1988a) L-Arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependant relaxation. Biochem Biophys Res Commun 153, 12511256.
  • Palmer RM, Ashton DS & Moncada S. (1988b) Vascular endothelial cells synthesize nitric oxide from L-Arginine. Nature 333, 664666.
  • Rajfer J, Aronson WJ, Bush PA, Dorey FJ & Ignarro LJ. (1992) Nitric oxide as a mediator of relaxation of the corpus cavernosum in response to nonadrenergic, noncholinergic neurotransmission. N Engl J Med 326, 9094.
  • Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J & Mishra A. (1997) The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 49, 822830.
  • Tangphao O, Grossmann M, Chalon S, Hoffman BB & Blaschke TF. (1999) Pharmacokinetics of intravenous and oral L-arginine in normal volunteers. Br J Clin Pharmacol 47, 261266.
  • Tong Y, Broderick G, Hypolite J & Levin RM. (1992) Correlations of purinergic, cholinergic and adrenergic functions in rabbit corporal cavernosal tissue. Pharmacology 45, 241249.
  • Tousoulis D, Antoniades C, Tentolouris C, Goumas G, Stefenadis C & Touzas P. (2002) L-Arginine in cardiovascular disease: dream or reality. Vasc Med 7, 203.
  • Wu G, Bazer FW, Cudd TA, Jobgen WS, Kim SW, Lassala A et al. (2007) Pharmacokinetics and safety of arginine supplementation in animals. J Nutr 137, 1673S1680S.
  • Wyatt AM, Steinert JR, Wheeler-Jones CP, Morgan AJ, Sugden D, Pearson JD et al. (2002) Early activation of the p42/p44MAPK pathway mediates adenosine-induced nitric oxide production in human endothelial cells: a novel calcium-insensitive mechanism. FASEB J 16, 15841594.
  • Zorgniotti AW & Lizza EF. (1994) Effect of large doses of the nitric oxide precursor L-arginine, on erectile dysfunction. Int J Impot Res 6, 3335.